ADVANCED SOLID CANCERS
Clinical trials for ADVANCED SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug ADCX-020 enters first human trials for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called ADCX-020 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody drug conjugate designed to deliver cancer-killing agents directly to tumor cells. The study will first find th…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug INV-6452 targets Hard-to-Treat breast cancers
Disease control Recruiting nowThis study tests an experimental drug called INV-6452 in adults with advanced breast cancer (HR+/HER2-) or other solid tumors that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 201 participants wil…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug BNT329 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called BNT329 in people with advanced solid tumors that have a specific marker (CA19-9). The main goals are to check safety and find the best dose. About 245 participants will take part. The drug works by targeting cancer cells and may help control tum…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New antibody PRL3-Zumab tested against advanced cancers
Disease control Recruiting nowThis study tests an experimental drug called PRL3-zumab in 52 adults with advanced solid tumors. The drug is given by IV every two weeks. Researchers want to see if it can slow cancer growth and how safe it is. Participants must have had no more than three prior treatments and be…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE2, PHASE3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Immune cell double punch takes on Hard-to-Treat tumors
Disease control Recruiting nowThis early-stage study is testing a new two-part immune therapy for people with advanced solid cancers like stomach, colon, or pancreatic cancer. The treatment combines special dendritic cells that guide the immune system to the tumor with CAR-T cells that directly attack cancer …
Matched conditions: ADVANCED SOLID CANCERS
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC